France· FR:65053285

CEFOTAXIME VIATRIS 1 g, poudre pour solution injectable (IM-IV)

A cefotaxime product containing céfotaxime sodique, registered in France by VIATRIS SANTE. The same ATC class is registered in 18 of our 19 countries.

ATC J01DD01

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about céfotaxime sodiqueAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cefotaxime is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DD01 (cefotaxime), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
10 of them publish a price we can compare per daily dose

Search cefotaxime products by name

Cefotaxime · ATC J01DD01

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefotaxime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cefotaxime · price per daily dose (4 g)

USD · FX 28 Sept 2026

ES Spain$14.21

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: CÉFOTAXIME SODIQUE
Manufacturer: VIATRIS SANTE
Country: France (FR)
ATC code: J01DD01
ATC class: Cefotaxime
Defined daily dose: 4 g, P
Reimbursed: No
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

cip13
3400955037514
10 flacon(s) en verre de 15 ml contenant 1,048 g de poudre

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

104 interactions on record for cefotaxime.

Graded by severity as the source publishes them — 21 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cefotaxime against other medicines How interaction checks work

Cefotaxime · interactions on record

104 records

21 moderate
83 info

Most severe, free to view

Sodium picosulfateA06AB08moderate
NeomycinA07AA01moderate
StreptomycinA07AA04moderate
KanamycinA07AA08moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefotaxime in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefotaxime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Cefotaxim Aptapharma, Cefotaxim Eberth
Belgium · Cefotaxime Noridem, Claforan
Bulgaria · Валоран, Тенатаксим
Cyprus · Oximezin, Syntoxime
Czechia · Cefotaxim Hameln, Cefotaxime Swyssi
Germany · Cefotaxim Eberth, Cefotaxim Fresenius
Denmark · Cefotaxim "hameln", Cefotaxim Mip
Estonia · Cefotaxime Mip, Valoran
Spain · Cefotaxima Normon, Cefotaxima Sala
Finland · Cefotaxim Hameln, Cefotaxim Mip Pharma
United Kingdom (Northern Ireland) · Cefotaxime Cox Pharmaceutical, Cefotaxime Hameln Pharma
Greece · Ciltiren, Gloryfen
Croatia · Cefotaksim Aptapharma, Cefotaksim Mip
Hungary · Cefotaxim Aptapharma, Cefotaxime Swyssi
Ireland · Cefotaxime Hameln, Cefotaxime Noridem Enterprises
Iceland · Cefotaxim Navamedic
Italy · Batixim, Cefotaxim Hameln
Lithuania · Cefotaxime Mip
Luxembourg · Cefotaxime Noridem, Claforan
Latvia · Cefotaxime Mip
Malta · Valoran
Netherlands · Cefotaxim Hameln
Norway · Cefotaxim Hameln, Cefotaxim Mip
Poland · Biotaksym, Cefotaxim Mip
Portugal · Antadar, Antadar I.M.
Romania · Cefotax, Cefotaxim Mip
Sweden · Cefotaxim Hameln, Cefotaxim Mip
Slovenia · Cefotaksim Aptapharma, Valoran
Slovakia · Cefotaxim Eberth, Cefotaxime Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dd8a0fe1-b78d-4bb7-a75a-d351823b27e4
GET /v1/drugs/dd8a0fe1-b78d-4bb7-a75a-d351823b27e4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65053285",
  "date_amm": "1998-08-24",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CÉFOTAXIME SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable",
  "voies_administration": "intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about cefotaxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console